WebNov 20, 2015 · Topokine Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT02609763 Other Study ID Numbers: TPK-SCALE-03 : First Posted: November 20, 2015 Key Record Dates: Last Update Posted: December 2, 2015 Last Verified: November 2015 Web00000000000. US-9820993-B2. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat. Active. 15-May-2013. A61K31/5575. 00. To view Topokine’s complete patent history, request access ».
Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS …
WebApr 22, 2016 · Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. Under the terms of the agreement, Allergan acquired Topokine Therapeutics for an upfront … WebTopokine Therapeutics president and CEO Murat Kalayoglu said, "This exclusive license further enhances our IP position, and we are excited to collaborate with him and the University of Bristol." Topokine’s lead program, XAF5 Gel, is a skin cream being developed for local reduction of excess subcutaneous fat. learn sign language game
Topokine Therapeutics - Crunchbase Company Profile
WebAbout Us. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. … WebFeb 9, 2024 · Assignee: Topokine Therapeutics, Inc. Inventors: Michael S. Singer, Murat V. Kalayoglu Methods and compositions for topical delivery of prostaglandins to … WebApr 28, 2016 · Apr 28th, 2016. Allergan has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for … learn sign language houston tx